Advertisement

Comparison between retransplantation of kidney and chronic dialysis

  • François Berthoux
  • Eric Alamartine
  • Nabil Diab
  • Jean-Pierre De Filippis
Part of the Transplantation and Clinical Immunology book series (TRAC, volume 29)

Abstract

Treatment of end stage renal failure (ESRF) is achieved either by chronic dialysis (haemodialysis or peritoneal dialysis) or by renal transplantation (RTx). The advantages of RTx over dialysis include lower mortality (annual death rate about 1% for transplanted patients, compared with 14% for dialysed patients in year 1995 for France) [1], better long-term rehabilitation of patients, regular improved graft survival (we can expect about 60% at 10 years under triple therapy) and lower cost (on a 10 year basis, the cost of transplantation is 5.5 times less than the cost of hospital dialysis). All these previous demonstrations were made with global data including 85–90% of first grafts.

Keywords

Peritoneal Dialysis Renal Replacement Therapy Triple Therapy Graft Failure Interval Time 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Berthoux F, Bernhein J, Geliert R et al. The project of the European Renal Association (ERA-EDTA) for an European nephrological network. Nephrol. Dial. Transplant. 1997, in press.Google Scholar
  2. 2.
    Mahoney RJ, Norman DJ, Colombe BW, Garovoy MR, Leeber DA. Identification of high and low risk second kidney grafts. Transplantation 1996; 61: 1349–1355.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1997

Authors and Affiliations

  • François Berthoux
  • Eric Alamartine
  • Nabil Diab
  • Jean-Pierre De Filippis

There are no affiliations available

Personalised recommendations